Menstrual Cycle and Women's Performance
The Relationship Between the Menstrual Cycle and Physical Performance in Women
1 other identifier
observational
32
1 country
1
Brief Summary
This study examines how different phases of the menstrual cycle are associated with selected performance and musculoskeletal parameters in physically active women aged 18-35 years. Participants will track their menstrual cycle using a mobile app for approximately 2 months and attend 3 laboratory visits scheduled to specific cycle phases. At each visit, participants will complete non-invasive assessments including lower-limb strength/performance testing, musculoskeletal measurements (muscle and tendon properties), body composition assessment, and symptom-related questionnaires. The goal is to improve understanding of physiological variability across the menstrual cycle and support evidence-based planning of training, testing, and clinical practice in women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 30, 2027
March 10, 2026
March 1, 2026
6 months
March 5, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phase-specific change in lower-limb neuromuscular performance across the menstrual cycle
Within-subject differences in lower-limb performance/strength outcomes measured during three laboratory visits scheduled to predefined menstrual cycle phases.
Assessed at 3 laboratory visits across approximately 2 months (cycle tracking period)
Secondary Outcomes (4)
Phase-specific differences in muscle mechanical properties
Assessed at 3 laboratory visits across approximately 2 months
Phase-specific differences in tendon mechanical properties
Assessed at 3 laboratory visits across approximately 2 months
Phase-specific differences in body composition variables
Assessed at 3 laboratory visits across approximately 2 months
Menstrual-related symptom profile across menstrual cycle phases
Collected during cycle tracking and at 3 laboratory visits across approximately 2 months
Study Arms (1)
Physically Active Women (18-35 years)
Women aged 18-35 years from the general population with occasional to recreational physical activity level. Participants undergo repeated non-invasive assessments across predefined menstrual cycle phases, including performance testing, musculoskeletal measurements, body composition assessment, and symptom tracking.
Interventions
Menstrual cycle monitoring using a mobile application for approximately 2 months to schedule laboratory visits to predefined cycle phases.
Repeated lower-limb performance/strength assessments during laboratory visits in different menstrual cycle phases.
Non-invasive assessment of selected muscle and tendon mechanical properties across cycle phases.
Body composition measurement and collection of self-reported menstrual-related symptoms at laboratory visits.
Eligibility Criteria
Premenopausal women aged 18-35 years from the general population with occasional to recreational physical activity, recruited for repeated within-subject assessments across predefined menstrual cycle phases.
You may qualify if:
- Female, age 18-35 years
- Premenopausal
- Occasional to recreational level of physical activity
- Willing and able to track menstrual cycle using a mobile application for approximately 2 months
- Willing and able to attend 3 laboratory visits scheduled to predefined menstrual cycle phases
- Able to provide written informed consent
You may not qualify if:
- Irregular menstrual cycle (outside protocol-defined regularity)
- Current pregnancy
- Use of hormonal medication for therapeutic purposes (per protocol)
- Current acute illness at time of testing
- Musculoskeletal injury of the lower limb limiting safe performance testing
- Contraindication to body composition assessment methods used in the study (e.g., BIA/DXA, per site protocol)
- Any other condition that, in the investigator's judgment, may interfere with safe participation or data quality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Physical Education and Sport, Charles University, José Martího 269/31
Prague, Prague, 16252, Czechia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2026
First Posted
March 10, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
March 30, 2027
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share